Now that we're in an era of personalized medicine, patients should not look at statistics and immediately think that they will determine their fate, says Tom Stockwell, patient navigator at the Fibrolamellar Cancer Foundation.
Now that we're in an era of personalized medicine, patients should not look at statistics and immediately think that they will determine their fate, says Tom Stockwell, patient navigator at the Fibrolamellar Cancer Foundation.
Stockwell's late son, Robert, was diagnosed with fibrolamellar cancer in 2013 at the age of 18. Even with published data and research on his cancer type, the family was still finding that it was difficult to get any true answers for his specific situation.
Now, Stockwell urges other patients not to just simply accept statistics and standards of care, and to advocate for themselves as an individual.
